Page 52 - ASME_NEMB_2016_Program
P. 52

Technical Program                                 TRACK 4





        This talk will report results of our recent studies on understanding the under-  Technical Presentation. NEMB2016-5988
        lying self-assembling processes in living systems used to generate unique
        nano-scale mechanical and photonic phenomena for realizing biological   Ying Li, zhiqiang Shen, University of Connecticut, Storrs, CT, United
        functions, including high-strength adhesive and fluorescent properties.   States
        Examples will be presented to illustrate how these processes can be manip-
        ulated to fabricate fluorescent peptide nanoparticles and tunable adhesive   Through nanomedicine, game-changing methods are emerging to deliver
        hydrogels for regenerative medicine.
                                                                drug molecules directly to diseased areas. One of the most promising of
                                                                these is the targeted delivery of drugs and imaging agents via drug carri-
        4:30pm Designing Biological Interactions of DNA-Assembled   er-based platforms. Such drug delivery systems can now be synthesized
        Nanoparticle Superstructures                            from a wide range of different materials, made in a number of different
                                                                shapes, and coated with an array of different organic molecules, including
        Technical Presentation. NEMB2016-5959                   ligands. If optimized, these systems can enhance the efficacy and specificity
                                                                of delivery compared those of non-targeted systems. Up to date, there are
        Leo Chou, Dana-Farber Cancer Institute, Boston, MA, United   several classes of nanoparticles (NPs) demonstrating the promising prop-
        States, Kyryl Zagorovsky, Vahid Raeesi, Warren Chan, University   erties as therapeutic carriers, such as solid lipid NPs, liposomes, quantum
                                                                dots, dendrimers and polymer micelles. By loading the drug molecules
        of Toronto, Toronto, ON, Canada                         into these NPs, their bio-distribution, pharmacokinetics and toxicity can be
                                                                dramatically improved, in comparison to their freely administrated counter-
        Nanoparticle drug delivery systems must overcome a series of physiologi-  parts. In this work, we have computationally designed a novel drug carrier,
        cal barriers to reach their sites-of-action. Although the in vivo behaviour of   Au-Polyethylene glycol-lipid NP. This NP is formed by the self-assembly of
        engineered nanomaterials can be tuned as a function of their physical pa-  the Au- Polyethylene glycol NPs, with random lipid molecules. Large scale
        rameters, design principles developed for one behavior often diverge from   coarse-grained molecular simulations have been performed to understand
        another. In other words, it is likely that the optimal size, shape, and surface   how the grafting density and molecular weight of tethered chains will affect
        chemistry of nanoparticles for traversing physiological barriers must evolve   the formed Au-Polyethylene glycol-lipid NPs. It has been found that the
        with their location and time within the body. To address this challenge, we   Au-Polyethylene glycol-lipid NPs could be more easily self-assembled when
        explored the construction of dynamic nanoparticle systems, using DNA   the grafting density and molecular weight of polyethylene glycol are en-
        assembly as tool for prototyping. We postulated that DNA programmability   larged and reduced, respectively. The phase diagram, in terms of the graft-
        provides stringent control over the structure and dynamics of nanomaterials   ing density and molecular weight of tethered polyethylene glycol chains, is
        for controlling their interactions with biological systems. Here, we describe   also computationally constructed, which could be used to guide experimen-
        how DNA-assembled nanoparticle superstructures interact with serum   tal synthesis of these Au-Polyethylene glycol-lipid NPs. The endocytosis of
        proteins, cells, and tissues as a function of their design, specifically in the   Au-Polyethylene glycol-lipid NPs is further explored through molecular simu-
        context of drug delivery and discuss emerging strategies for therapeutic   lations and compared with liposomes.
        design.
                                                                5:10pm Exploring the Impact of Local Ligand Flexibility on B Lym-
        Our study used spherical and rod-shaped metal nanoparticles of varying
        sizes (e.g. 3, 5, and 15 nm) as models. We functionalized these nanopar-  phocyte Signaling via a Platform DNA Origami Nanostructure
        ticles with oligonucleotides and poly(ethylene glycol) as ligands, and
        combined them in different combinations using complementary oligonucle-  Technical Presentation. NEMB2016-6008
        otides linkers to form superstructures with distinct architectures. We charac-
        terized these materials using dynamic light scattering and electron micros-  Christopher Lucas, Emily N. Briggs, Randy A. Patton, Molly Y.
        copy, followed by a systematic assessment of their interactions with serum   Mollica, John C. Byrd, Virginia M. Sanders, The Ohio State Uni-
        proteins, cells, and tissues. Superstructure interactions with serum were   versity, Columbus, OH, United States, Carlos Castro, Ohio State
        analyzed by polyacrylamide gel electrophoresis (PAGE); cellular uptake   university, Columbus, OH, United States
        and biodistribution was measured by inductively-coupled atomic emission
        spectroscopy, and visualized by electron microscopy and whole-animal
        fluorescence imaging.                                   Scaffolded DNA origami molecular self-assembly allows for the generation
                                                                of two- and three-dimensional DNA nanostructures that may be functional-
                                                                ized in a highly specific manner with biological molecules to induce molecu-
        Our results show that DNA assembly can synthesize a large number of   lar and cellular responses that may be studied at the single cell scale. Previ-
        nanoparticle superstructures with controlled size, surface chemistry, and
        architectures. Architecture was especially important in determining the   ous work demonstrated that the level of intracellular signaling is dependent
        accessibility of ligands to nuclease degradation and recognition by macro-  upon ligand proximity, an effect that may be controlled through the employ-
        phages. In essence, it determines what the biological system “sees” when   ment of DNA nanostructures. However, whether local flexibility of a specific
        encountering a superstructure nanomaterial. By controlling architecture   ligand affects the level of intracellular signal generated within single B cells
                                                                remains unexplored. Here we describe the generation of a Ligand Presen-
        and surface chemistry of the superstructures, we were able to engineer
        DNA-linked superstructures that are serum stable for up to 8 hours and   tation Platform (LPP) DNA nanostructure that allows for precise control of
        resist macrophage uptake and sequestration. In vivo, these design opti-  the number, spatial arrangement, and local flexibility via the length of linker
        mizations improved superstructure accumulation within a tumor xenograft   attaching the ligand to the platform. The ligand linker is a single-stranded
        model, and permitted tumour-specific imaging contrast at 24 hours post-in-  biotinylated DNA oligo that extends from the nanostructure allowing for
                                                                streptavidin and biotinylated anti-CD40 antibody attachment and precise
        jection. We also investigated the use of DNA assembly to integrate pho-
        tothermal gold nanorods and the chemotherapeutic doxorubicin into su-  control over ligand linker length. Well-formed LPP DNA nanostructures were
        perstructures. This design strategy placed DNA melting and consequently   confirmed via agarose gel electrophoresis, transmission electron microsco-
        superstructure integrity under optical control, thereby allowing light-trig-  py, and atomic force microscopy. Effective streptavidin and biotin-labeled
        gered drug release and intracellular uptake. Overall, we showed that DNA   anti-CD40 antibody incorporation to LPP DNA nanostructures was assessed
                                                                by fluorescent agarose gel electrophoresis and transmission electron mi-
        assembly of dynamic nanoparticle systems permits emerging therapeutic
        design strategies as well as new ways to design their interactions with bio-  croscopy. In addition, fluorescent microscopy experiments revealed that an-
        logical systems.                                        ti-CD40 functionalized LPP DNA nanostructures attached to the CH12.LX B
                                                                cell surface in a specific manner relative to a species-/isotype-matched con-
                                                                trol antibody functionalized LPP nanostructure. Our initial functional experi-
        4:50pm Computational study on self-assembly of Au-Polyeth-
   52   ylene glycol-lipid nanoparticles                        ments revealed that immobilization of an anti-CD40 antibody on a platform
                                                                DNA nanostructure induced significant increases in NF-kappaB activation in
                                                                single murine CH12.LX B cells relative to soluble antibodies at equal concen-
                                                                trations. Furthermore, the strength of signal induction of CD40-dependent
   47   48   49   50   51   52   53   54   55   56   57